This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Rajkomar K, Koea JB (2017) Intrahepatic cholangiocarcinoma. Blumgart’s surgery of the liver, biliary tract and pancreas, 6th edition, Elsevier, pp 32-59.
Metcalfe MS, Bridgewater FH, Mullin EJ, Mullin EJ, Maddern GJ. Useless and dangerous: fine needle aspiration of hepatic colorectal metastases. BMJ. 2004;328:507–8.
De Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29:3140–5.
Ribero D, Pinna AD, Guglielmi A, Ponti A, Nuzzo G, Giulini SM, et al. Surgical approaches for long term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients. Arch Surg. 2012;147:1107–13.
Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248:84–96.
Jan YY, Yeh CN, Yeh TS, Hwang TL, Chen MF. Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma. World J Surg. 2005;29:894–8.
Yoh T, Hatano E, Seo S, Okuda Y, Fuji H, Ikeno Y, et al. Long-term survival of recurrent intrahepatic cholangiocarcinoma: the impact and selection of repeat surgery. World J Surg. 2018;42:1848–56.
Zhang SJ, Hu P, Wang N, Shen Q, Sun AX, Kuang M, et al. Thermal ablation versus repeated hepatic resection for recurrent intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2013;20:3596–602.
Si A, Li J, Xing X, Lei Z, Xia Y, Yan Z, et al. Effectiveness of repeat hepatic resection for patients with recurrent intrahepatic cholangiocarcinoma: factors associated with long-term outcomes. Surgery. 2017;161:897–908.
Ibrahim SM, Mulcahy MF, Lewandowski RJ, Sato KT, Ryu RK, Masterson EJ, et al. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. Cancer. 2008;113:2119–28.
Mouli S, Memon K, Baker T, Benson AB 3rd, Mulcahy MF, Gupta R, et al. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol. 2013;24:1227–34.
Högberg J, Rizell M, Hultborn R, Svensson J, Henrikson O, Mölne J, et al. Heterogeneity of microsphere distribution in resected liver and tumour tissue following selective intrahepatic radiotherapy. EJNMMI Res. 2014;4:48.
Högberg J, Rizell M, Hultborn R, Svensson J, Henrikson O, Mölne J, et al. Simulation model of microsphere distribution for selective internal radiation therapy agrees with observations. Int J Radiat Oncol Biol Phys. 2016;96:414–21.
Hemmingsson J, Högberg J, Mölne J, Svensson J, Gjertsson P, Rizell M, et al. Autoradiography and biopsy measurements of a resected hepatocellular carcinoma treated with 90 yttrium radioembolization demonstrate large absorbed dose heterogeneities. Adv Radiat Oncol. 2018;3:439–46.
Dhingra S, Schwartz M, Kim E, Leung NW, Chan M, Lin J, et al. Histological changes in nontumoral liver secondary to radioembolization of hepatocellular carcinoma with yittrium 90-impregnated microspheres: report of two cases. Semin Liver Dis. 2014;34:465–8.
Kim JH, Yoon HK, Sung KB, Ko GY, Gwon DI, Shin JH, et al. Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes. Cancer. 2008;113:1614–22.
Lau WY, Kennedy AS, Kim YH, Lai HK, Lee RC, Leung TW, et al. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Int J Radiat Oncol Biol Phys. 2012;82:401–7.
Robles R, Figueras J, Turrion VS, Margarit C, Moya A, Varo E, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg. 2004;239:265–71.
Sapisochin G, Fernandez de Sevilla E, Echeverri J, Charco R. Liver transplantation for cholangiocarcinoma: current status and new insights. World J Hepatol. 2015;7:2396–403.
Sapisochin G, Facciuto M, Rubbia-Brandt L, Marti J, Mehta N, Yao FY, et al. For iCCA international consortium. Liver transplantation for “very early” intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment. Hepatology. 2016;64:1178–88.
This manuscript was not supported by any funding.
Conflict of Interest
The authors declare that they have no conflict of interest.
Statement of Informed Consent
Written informed consent was obtained from the patient’s relatives for publication of this case report and any accompanying images.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Oguz, S., Kucukaslan, H., Topaloglu, S. et al. Is it Possible to Increase Survival of Patients with Intrahepatic Cholangiocarcinoma? A Case Report. J Gastrointest Canc 52, 342–346 (2021). https://doi.org/10.1007/s12029-020-00446-4